COUNCIL REGULATION (EEC) N°2377/90

laying down a Community procedure for
the establishment of maximum residue limits of
veterinary medicinal products in foodstuffs of animal origin

ANNEX I

List of pharmacologically active substances
for which maximum residue levels have been fixed

1.	Anti-infectious agents

1.1.	Chemotherapeutics

1.1.1.

Sulfonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[All substances belonging to the sulfonamide group	Parent drug	All food producing species	100 mg/kg	Muscle	The combined residues of all substances within the sulfonamide group should; not exceed 100 mg/kg]1
			100 mg/kg	Liver
			100 mg/kg	Kidney
			100 mg/kg	Fat
		Bovine, ovine, caprine	100 mg/kg	Milk

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

1.1.2.

Diamino pyrimidine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Baquiloprim	Baquiloprim	Bovine	300 mg/kg	Liver	]1
			150 mg/kg	Kidney
			10 mg/kg	Fat
			30 mg/kg	Milk
		Porcine	50 mg/kg	Liver
			50 mg/kg	Kidney
			40 mg/kg	Fat and skin
[Trimethoprim	Trimethoprim	All food producing species except equidae	50 mg/kg	Muscle (for fin fish this MRL relates to ”muscle and skin in natural proportions”)	Not for use in animals from which eggs are produced for human consumption
			50 mg/kg	Fat (for porcine and poultry species this MRL relates to ”skin and fat in natural proportions”)
			50 mg/kg	Liver
			50 mg/kg	Kidney
			50 mg/kg	Milk
		Equidae	100 mg/kg	Muscle	]2
			100 mg/kg	Fat
			100 mg/kg	Liver
			100 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

1.2.	Antibiotics

1.2.1.

Penicillins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Amoxicyllin	Amoxicyllin	All food producing species	50 mg/kg	Muscle
			50 mg/kg	Fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
			4 mg/kg	Milk
Ampicillin	Ampicillin	All food producing species	50 mg/kg	Muscle
			50 mg/kg	Fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
			4 mg/kg	Milk
Benzylpenicillin	Benzylpenicillin	All food producing species	50 mg/kg	Muscle
			50 mg/kg	Fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
			4 mg/kg	Milk
Cloxacillin	Cloxacillin	All food producing species	300 mg/kg	Muscle
			300 mg/kg	Fat
			300 mg/kg	Liver
			300 mg/kg	Kidney
			30 mg/kg	Milk
Dicloxacillin	Dicloxacillin	All food producing species	300 mg/kg	Muscle	]1
			300 mg/kg	Fat
			300 mg/kg	Liver
			300 mg/kg	Kidney
			30 mg/kg	Milk
[Nafcillin	Nafcillin	Bovine	300 mg/kg	Muscle	For intramammary use only]2
			300 mg/kg	Fat
			300 mg/kg	Liver
			300 mg/kg	Kidney
			30 mg/kg	Milk
[Oxacillin	Oxacillin	All food producing species	300 mg/kg	Muscle	]3
			300 mg/kg	Fat
			300 mg/kg	Liver
			300 mg/kg	Kidney
			30 mg/kg	Milk
[Penethamate	Benzylpenicillin	Bovine	50 mg/kg	Muscle	]4,5
			50 mg/kg	Fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
			4 mg/kg	Milk
		Porcine	50 mg/kg	Muscle
			50 mg/kg	Fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
[Phenoxymethyl- -penicillin	Phenoxymethyl- -penicillin	Porcine	25 mg/kg	Muscle	]6
			25 mg/kg	Liver
			25 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 807/2001 of 25 April 2001 (OJ N° L 118, 27.4.2001)

3. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

4. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

5. Commision Regulation (EC) N° 2757/1999 of 22 December 1999 (OJ N° L 331, 23.12.1999)

6. Commision Regulation (EC) N° 1286/2000 of 19 June 2000 (OJ N° L 145, 20.6.2000)

1.2.2.

Cephalosporins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Cefacetrile	Cefacetrile	Bovine	125 mg/kg	Milk	For intramammary use only]1
[Cefalexin	Cefalexin	Bovine	200 mg/kg	Muscle	]2
			200 mg/kg	Fat
			200 mg/kg	Liver
			1000 mg/kg	Kidney
			100 mg/kg	Milk
[Cefapirin	Sum of cephapirin and acetyl desacetylcephapirin	Bovine	50 mg/kg	Muscle	]3
			50 mg/kg	Fat
			100 mg/kg	Kidney
			60 mg/kg	Milk
[Cefazolin	Cefazolin	Bovine, caprine, ovine	50 mg/kg	Milk	]4
[Cefoperazone	Cefoperazone	Bovine	50 mg/kg	Milk	]5
[Cefquinone	Cefquinone	Bovine	50 mg/kg	Muscle	]6,7
			50 mg/kg	Fat
			100 mg/kg	Liver
			200 mg/kg	Kidney
			20 mg/kg	Milk
		Porcine	100 mg/kg	Muscle
			50 mg/kg	Skin and fat
			200 mg/kg	Liver
			200 mg/kg	Kidney
[Ceftiofur	Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur	Bovine	1000 mg/kg	Muscle	]8
			2000 mg/kg	Fat
			2000 mg/kg	Liver
			6000 mg/kg	Kidney
			100 mg/kg	Milk, not for intramammary use
		Porcine	1000 mg/kg	Muscle
			2000 mg/kg	Fat
			2000 mg/kg	Liver
			6000 mg/kg	Kidney

1. Commision Regulation (EC) N° 2162/2001 of 7 November 2001 (OJ N° L 291, 8.11.2001)

2. Commision Regulation (EC) N° 2728/1999 of 20 December 1999 (OJ N° L 328, 22.12.1999)

3. Commision Regulation (EC) N° 1553/2001 of 30 July 2001 (OJ N° L 205, 31.7.2001)

4. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

5. Commision Regulation (EC) N° 807/2001 of 25 April 2001 (OJ N° L 118, 27.4.2001)

6. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

7. Commision Regulation (EC) N° 1931/1999 of 9 September 1999 (OJ N° L 240, 10.9.1999)

8. Commision Regulation (EC) N° 804/1999 of 16 April 1999 (OJ N° L 102, 17.4.1999)

1.2.3.

Quinolones

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provision
[Danofloxacin	Danofloxacin	All food producing species except bovine, ovine, caprine and poultry	100 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")
			50 mg/kg	Fat (for porcine species this MRL relates to "skin and fat in natural proportions")
			200 mg/kg	Liver
			200 mg/kg	Kidney
		Bovine, ovine, caprine	200 mg/kg	Muscle
			100 mg/kg	Fat
			400 mg/kg	Liver
			400 mg/kg	Kidney
			30 mg/kg	Milk
		Poultry	200 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			100 mg/kg	Skin and fat
			400 mg/kg	Liver
			400 mg/kg	Kidney
Difloxacin	Difloxacin	All food producing species except bovine, ovine, caprine, porcine and poultry	300 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")
			100 mg/kg	Fat
			800 mg/kg	Liver
			600 mg/kg	Kidney
		Bovine, ovine, caprine	400 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			100 mg/kg	Fat
			1400 mg/kg	Liver
			800 mg/kg	Kidney
		Porcine	400 mg/kg	Muscle
			100 mg/kg	Skin and fat
			800 mg/kg	Liver
			800 mg/kg	Kidney
		Poultry	300 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			400 mg/kg	Skin and fat
			1900 mg/kg	Liver
			600 mg/kg	Kidney
Enrofloxacin	Sum of enrofloxacin and ciprofloxacin	All food producing species except bovine, ovine, caprine, porcine, rabbits and poultry	100 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")
			100 mg/kg	Fat
			200 mg/kg	Liver
			200 mg/kg	Kidney
		Bovine, ovine, caprine	100 mg/kg	Muscle
			100 mg/kg	Fat
			300 mg/kg	Liver
			200 mg/kg	Kidney
			100 mg/kg	Milk
		Porcine, rabbits	100 mg/kg	Muscle
			100 mg/kg	Fat (for porcine species this MRL relates to "skin and fat in natural proportions")
			200 mg/kg	Liver
			300 mg/kg	Kidney
		Poultry	100 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			100 mg/kg	Skin and fat
			200 mg/kg	Liver
			300 mg/kg	Kidney
Flumequine	Flumequine	All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish	200 mg/kg	Muscle
			250 mg/kg	Fat
			500 mg/kg	Liver
			1000 mg/kg	Kidney
		Bovine, ovine, caprine, porcine	200 mg/kg	Muscle
			300 mg/kg	Fat (for porcine species this MRL relates to "skin and fat in natural proportions")
			500 mg/kg	Liver
			1500 mg/kg	Kidney
			50 mg/kg	Milk
		Poultry	400 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			250 mg/kg	Skin and fat
			800 mg/kg	Liver
			1000 mg/kg	Kidney
		Fin fish	600 mg/kg	Muscle and skin in natural poportions	]1
[Marbofloxacin	Marbofloxacin	Bovine	150 mg/kg	Muscle	]2
			50 mg/kg	Fat
			150 mg/kg	Liver
			150 mg/kg	Kidney
			75 mg/kg	Milk
		Porcine	150 mg/kg	Muscle
			50 mg/kg	Skin and fat
			150 mg/kg	Liver
			150 mg/kg	Kidney
Sarafloxacin	Sarafloxacin	Chicken	10 mg/kg	Fat and skin	]3
			100 mg/kg	Liver
		Salmonidae	30 mg/kg	Muscle and skin in natural proportions

1. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

2. Commision Regulation (EC) N° 2338/2000 of 20 October 2000 (OJ N° L 269, 21.10.2000)

3. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

1.2.4.

Macrolides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Acetylisovaleryltylosin	Sum of acetylisovaleryltylosin and 3-O-acetyltylosin	Porcine	50 mg/kg	Muscle	]1
			50 mg/kg	Skin and fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
[Erythromycin	Erythromycin A	All food producing species	200 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")	]2
			200 mg/kg	Fat (for porcine species this MRL relates to "skin and fat in natural proportions")
			200 mg/kg	Liver
			200 mg/kg	Kidney
			40 mg/kg	Milk
			150 mg/kg	Eggs
[Spiramycin	Sum of spiramycin and neospiramycin	Bovine	200 mg/kg	Muscle	]3,4
			300 mg/kg	Fat
			300 mg/kg	Liver
			300 mg/kg	Kidney
			200 mg/kg	Milk
		Chicken	200 mg/kg	Muscle
			300 mg/kg	Skin and fat
			400 mg/kg	Liver
	Spiramycin 1	Porcine	250 mg/kg	Muscle
			2000 mg/kg	Liver
			1000 mg/kg	Kidney
[Tilmicosin	Tilmicosin	All food producing species except poultry	50 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")
			50 mg/kg	Fat (for porcine species this MRL relates to "skin and fat in natural proportions")
			1000 mg/kg	Liver
			1000 mg/kg	Kidney
			50 mg/kg	Milk
		Poultry	75 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			75 mg/kg	Skin and fat
			1000 mg/kg	Liver
			250 mg/kg	Kidney
Tylosin	Tylosin A	All food producing species	100 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")	]5
			100 mg/kg	Fat (for porcine and poultry species this MRL relates to "skin and fat in natural proportions")
			100 mg/kg	Liver
			100 mg/kg	Kidney
			50 mg/kg	Milk
			200 mg/kg	Eggs

1. Commision Regulation (EC) N° 77/2002 of 17 January 2002 (OJ N° L 16, 18.1.2002)

2. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

3. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

4. Commision Regulation (EC) N° 2593/1999 of 8 December 1999 (OJ N° L 315, 9.12.1999)

5. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

1.2.5.

Florfenicol and related compounds

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Florfenicol	Sum of florfenicol and its metabolites measured as florfenicol-amine	All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish	100 mg/kg	Muscle
			200 mg/kg	Fat
			2000 mg/kg	Liver
			300 mg/kg	Kidney
		Bovine, ovine, caprine	200 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			3000 mg/kg	Liver
			300 mg/kg	Kidney
		Porcine	300 mg/kg	Muscle
			500 mg/kg	Skin and fat
			2000 mg/kg	Liver
			500 mg/kg	Kidney
		Poultry	100 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			200 mg/kg	Skin and fat
			2500 mg/kg	Liver
			750 mg/kg	Kidney
		Fin fish	1000 mg/kg	Muscle and skin in natural proportion	]1
[Thiamphenicol	Thiamphenicol	Bovine	50 mg/kg	Muscle	]2
			50 mg/kg	Fat
			50 mg/kg	Liver
			50 mg/kg	Kidney
			50 mg/kg	Milk
		Chicken Not for use in animals from which eggs are produced for human consumption	50 mg/kg	Muscle
			50 mg/kg	Skin and fat
			50 mg/kg	Liver
			50 mg/kg	Kidney

1. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

2. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

1.2.6.

Tetracyclines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Chlortetracycline	Sum of parent drug and its 4-epimer	All food producing species	100 mg/kg	Muscle
			300 mg/kg	Liver
			600 mg/kg	Kidney
			100 mg/kg	Milk
			200 mg/kg	Eggs
Doxycycline	Doxycycline	Bovine Not for use in animals from which milk is produced for human consumption	100 mg/kg	Muscle
			300 mg/kg	Liver
			600 mg/kg	Kidney
		Porcine	100 mg/kg	Muscle
			300 mg/kg	Fat and skin
			300 mg/kg	Liver
			600 mg/kg	Kidney
		Poultry Not for use in animals from which eggs are produced for human consumption	100 mg/kg	Muscle
			300 mg/kg	Fat and skin
			300 mg/kg	Liver
			600 mg/kg	Kidney
Oxytetracycline	Sum of parent drug and its 4-epimer	All food producing species	100 mg/kg	Muscle
			300 mg/kg	Liver
			600 mg/kg	Kidney
			100 mg/kg	Milk
			200 mg/kg	Eggs
Tetracycline	Sum of parent drug and its 4-epimer	All food producing species	100 mg/kg	Muscle	]1
			300 mg/kg	Liver
			600 mg/kg	Kidney
			100 mg/kg	Milk
			200 mg/kg	Eggs

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

1.2.7.

Naphtalene-ringed ansamycin

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Rifaximin	Rifaximin	Bovine	60 mg/kg	Milk	]1

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

1.2.8.

Pleuromutilines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Tiamulin	Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin	Porcine	100 mg/kg	Muscle	]1.2.3
			500 mg/kg	Liver
		Chicken	100 mg/kg	Muscle
			100 mg/kg	Skin and fat
			1000 mg/kg	Liver
	Tiamulin	Chicken	1000 mg/kg	Eggs
	Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin	Turkey	100 mg/kg	Muscle
			100 mg/kg	Skin and fat
			300 mg/kg	Liver
		Rabbits	100 mg/kg	Muscle
			500 mg/kg	Liver
[Valnemulin	Valnemulin	Porcine	50 mg/kg	Muscle	]4
			500 mg/kg	Liver
			100 mg/kg	Kidney

1. Commision Regulation (EC) N° 2728/1999 of 20 December 1999 (OJ N° L 328, 22.12.1999)

2. Commision Regulation (EC) N° 2338/2000 of 20 October 2000 (OJ N° L 269, 21.10.2000)

3. Commision Regulation (EC) N° 807/2001 of 25 April 2001 (OJ N° L 118, 27.4.2001)

4. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

1.2.9.

Lincosamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Lincomycin	Lincomycin	All food producing species	100 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")	]1
			50 mg/kg	Fat (for porcine and poultry species this MRL relates to "skin and fat in natural proportions")
			500 mg/kg	Liver
			1500 mg/kg	Kidney
			150 mg/kg	Milk
			50 mg/kg	Eggs
[Pirlimycin	Pirlimycin	Bovine	100 mg/kg	Muscle	]2
			100 mg/kg	Fat
			1000 mg/kg	Liver
			400 mg/kg	Kidney
			100 mg/kg	Milk

1. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

2. Commision Regulation (EC) N° 2338/2000 of 20 October 2000 (OJ N° L 269, 21.10.2000)

1.2.10.

Aminoglycosides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Apramycin	Apramycin	Bovine	1000 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption]1
			1000 mg/kg	Fat
			10000 mg/kg	Liver
			20000 mg/kg	Kidney
[Dihydrostreptomycin	Dihydrostreptomycin	Bovine, ovine	500 mg/kg	Muscle	]2
			500 mg/kg	Fat
			500 mg/kg	Liver
			1000 mg/kg	Kidney
			200 mg/kg	Milk
		Porcine	500 mg/kg	Muscle
			500 mg/kg	Skin and fat
			500 mg/kg	Liver
			1000 mg/kg	Kidney
[Gentamicin	Sum of gentamicin C1, gentamicin C1a, gentamicin C2 and gentamicin C2a	Bovine	50 mg/kg	Muscle	]3
			50 mg/kg	Fat
			200 mg/kg	Liver
			750 mg/kg	Kidney
			100 mg/kg	Milk
		Porcine	50 mg/kg	Muscle
			50 mg/kg	Skin and fat
			200 mg/kg	Liver
			750 mg/kg	Kidney
[Neomycin (including framycetin)	Neomycin B	All food producing species	500 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")
			500 mg/kg	Fat (for porcine and poultry species this MRL relates to "skin and fat in natural proportions")
			500 mg/kg	Liver
			5000 mg/kg	Kidney
			1500 mg/kg	Milk
			500 mg/kg	Eggs
Paromomycin	Paromomycin	All food producing species	500 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")	Not for use in animals from which milk and eggs are produced for human consumption
			1500 mg/kg	Liver
			1500 mg/kg	Kidney
Spectinomycin	Spectinomycin	All food producing species except ovine	300 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")	Not for use in animals from which eggs are produced for human consumption
			500 mg/kg	Fat (for porcine and poultry species this MRL relates to "skin and fat in natural proportions")
			1000 mg/kg	Liver
			5000 mg/kg	Kidney
			200 mg/kg	Milk
		Ovine	300 mg/kg	Muscle	]4
			500 mg/kg	Fat
			2000 mg/kg	Liver
			5000 mg/kg	Kidney
			200 mg/kg	Milk
[Streptomycin	Streptomycin	Bovine, ovine	500 mg/kg	Muscle	]5
			500 mg/kg	Fat
			500 mg/kg	Liver
			1000 mg/kg	Kidney
			200 mg/kg	Milk
		Porcine	500 mg/kg	Muscle
			500 mg/kg	Skin and fat
			500 mg/kg	Liver
			1000 mg/kg	Kidney

1. Commision Regulation (EC) N° 1931/1999 of 9 September 1999 (OJ N° L 240, 10.9.1999)

2. Commision Regulation (EC) N° 1530/2002 of 27 August 2002 (OJ N° L1530, 28.8.2002)

3. Commision Regulation (EC) N° 868/2002 of 24 May 2002 (OJ N° L 137, 25.5.2002)

4. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

5. Commision Regulation (EC) N° 1530/2002 of 27 August 2002 (OJ N° L1530, 28.8.2002)

1.2.11.

Other antibiotics

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Novobiocin	Novobiocin	Bovine	50 mg/kg	Milk	]1

1. Commision Regulation (EC) N° 2593/1999 of 8 December 1999 (OJ N° L 315, 9.12.1999)

1.2.12.

Polypeptides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Bacitracin	Sum of bacitracin A, bacitracin B, and bacitracin C	Bovine	100 mg/kg	Milk	]1

1. Commision Regulation (EC) N° 1478/2001 of 18 July 2001 (OJ N° L 195, 19.7.2001)

1.2.13.

Beta-lactamase inhibitors

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Clavulanic acid	Clavulanic acid	Bovine	100 mg/kg	Muscle	]1
			100 mg/kg	Fat
			200 mg/kg	Liver
			400 mg/kg	Kidney
			200 mg/kg	Milk
		Porcine	100 mg/kg	Muscle
			100 mg/kg	Skin and fat
			200 mg/kg	Liver
			400 mg/kg	Kidney

1. Commision Regulation (EC) N° 1553/2001 of 30 July 2001 (OJ N° L 205, 31.7.2001)

1.2.14.

Polymyxins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Colistin	Colistin	All food producing species	150 mg/kg	Muscle (for fin fish this MRL relates to "muscle and skin in natural proportions")	]1
			150 mg/kg	Fat (for porcine and poultry species this MRL relates to "skin and fat in natural proportions")
			150 mg/kg	Liver
			200 mg/kg	Kidney
			50 mg/kg	Milk
			300 mg/kg	Eggs

1. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

2.	Antiparasitic agents

2.1.	Agents acting against endoparasites

2.1.1.

Salicylanilides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Closantel	Closantel	Bovine	1000 mg/kg	Muscle	]1
			3000 mg/kg	Fat
			1000 mg/kg	Liver
			3000 mg/kg	Kidney
		Ovine	1500 mg/kg	Muscle
			2000 mg/kg	Fat
			1500 mg/kg	Liver
			5000 mg/kg	Kidney
[Rafoxanide	Rafoxanide	Bovine	30 mg/kg	Muscle	]2
			30 mg/kg	Fat
			10 mg/kg	Liver
			40 mg/kg	Kidney
		Ovine	100 mg/kg	Muscle
			250 mg/kg	Fat
			150 mg/kg	Liver
			150 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 1478/2001 of 18 July 2001 (OJ N° L 195, 19.7.2001)

2.1.2.

Tetra-hydro-imidazoles (imidazolthiazoles)

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Levamisol	Levamisol	Bovine, ovine, porcine, poultry	10 mg/kg	Muscle	]1
			10 mg/kg	Fat
			100 mg/kg	Liver
			10 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2.1.3.

Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Albendazole	Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole	Bovine, ovine	100 mg/kg	Muscle	]1
			100 mg/kg	Fat
			1000 mg/kg	Liver
			500 mg/kg	Kidney
			100 mg/kg	Milk
[Albendazole oxide	Sum of albendazole oxide, albendazole sulphone, and albendazole 2-aminosulphone, expressed as albendazole	Bovine, ovine	100 mg/kg	Muscle	]2
			100 mg/kg	Fat
			1000 mg/kg	Liver
			500 mg/kg	Kidney
			100 mg/kg	Milk
[Febantel	Sum of extractable residues which may be oxidised in oxfendazole sulphone	Bovine, ovine, porcine, equidae	50 mg/kg	Muscle
			50 mg/kg	Fat
			500 mg/kg	Liver
			50 mg/kg	Kidney
		Bovine, ovine	10 mg/kg	Milk
Fenbendazole	Sum of extractable residues which may be oxidised in oxfendazole sulphone	Bovine, ovine, porcine, equidae	50 mg/kg	Muscle	]3
			50 mg/kg	Fat
			500 mg/kg	Liver
			50 mg/kg	Kidney
		Bovine, ovine	10 mg/kg	Milk
[Flubendazole	Sum of flubendazole and (2-amino 1H-benzimidazole-5-yl) (4-fluorophenyl) methanone	Porcine, chicken, game birds	50 mg/kg	Muscle	]4,5
			50 mg/kg	Skin and fat
			400 mg/kg	Liver
			300 mg/kg	Kidney
	Flubendazole	Chicken	400 mg/kg	Eggs
	Sum of flubendazole and (2-amino 1H-benzimidazol-5-yl) (4fluorophenyl) methanone	Turkey	50 mg/kg	Muscle
			50 mg/kg	Skin and fat
			400 mg/kg	Liver
			300 mg/kg	Kidney
[Mebendazole	Sum of mebendazole methyl (5-(1-hydroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents	Ovine, caprine, equidae	60 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption]6
			60 mg/kg	Fat
			400 mg/kg	Liver
			60 mg/kg	Kidney
[Netobimin	Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole	Bovine, ovine	100 mg/kg	Muscle	For oral use only]7
			100 mg/kg	Fat
			1000 mg/kg	Liver
			500 mg/kg	Kidney
			100 mg/kg	Milk
[Oxfendazole	Sum of extractable residues which may be oxidised in oxfendazole sulphone	Bovine	10 mg/kg	Milk
		Bovine, ovine, porcine, equidae	50 mg/kg	Muscle
			50 mg/kg	Fat
			500 mg/kg	Liver
			50 mg/kg	Kidney
			10 mg/kg	Milk
Oxibendazole	Oxibendazole	Porcine	100 mg/kg	Muscle
			500 mg/kg	Skin and fat
			200 mg/kg	Liver
			100 mg/kg	Kidney
Thiabendazole	Sum of thiabendazole and 5-hydroxythiabendazole	Bovine	100 mg/kg	Muscle
			100 mg/kg	Fat
			100 mg/kg	Liver
			100 mg/kg	Kidney
			100 mg/kg	Milk
Triclabendazole	Sum of extractable residues that may be oxidised to ketotriclabendazole	Bovine, ovine	100 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption]8
			100 mg/kg	Liver
			100 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 2393/1999 of 11 November 1999 (OJ N° L 290, 12.11.1999)

3. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

4. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

5. Commision Regulation (EC) N° 2385/1999 of 10 November 1999 (OJ N° L 288, 11.11.1999)

6. Commision Regulation (EC) N° 1680/2001 of 22 August 2001 (OJ N° L 227, 23.8.2001)

7. Commision Regulation (EC) N° 807/2001 of 25 April 2001 (OJ N° L 118, 27.4.2001) and Corrigendum (OJ N° L133, 16.5.2001)

8. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2.1.4.

Phenol derivatives including salicylanides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Nitroxinil	Nitroxinil	Bovine, ovine	400 mg/kg	Muscle	]1
			200 mg/kg	Fat
			20 mg/kg	Liver
			400 mg/kg	Kidney
[Oxyclozanide	Oxyclozanide	Bovine	20 mg/kg	Muscle
			20 mg/kg	Fat
			500 mg/kg	Liver
			100 mg/kg	Kidney
			10 mg/kg	Milk
		Ovine	20 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption ]2
			20 mg/kg	Fat
			500 mg/kg	Liver
			100 mg/kg	Kidney

1. Commision Regulation (EC) N° 997/1999 of 11 May 1999 (OJ N° L 122,12.5.1999)

2. Commision Regulation (EC) N° 1181/2002 of 1 July 2002 (OJ N° L 172, 2.7.2002)

2.1.5.

Benzenesulphonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Clorsulon	Clorsulon	Bovine	35 mg/kg	Muscle	]1
			100 mg/kg	Liver
			200 mg/kg	Kidney

1. Commision Regulation (EC) N° 1942/1999 of 10 September 1999 (OJ N° L 241, 11.9.1999)

2.1.6.

Piperazine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Piperazine	Piperazine	Porcine	400 mg/kg	Muscle	]1
			800 mg/kg	Skin and fat
			2000 mg/kg	Liver
			1000 mg/kg	Kidney
		Chicken	2000 mg/kg	Eggs

1. Commision Regulation (EC) N° 868/2002 of 24 May 2002 (OJ N° L 137, 25.5.2002)

2.2.	Agents acting against ecto-parasites

2.2.1.

Organophosphates

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Coumafos	Coumafos	Bees	100 mg/kg	Honey	]1
[Diazinon	Diazinon	Bovine,ovine, caprine, porcine	20 mg/kg	Muscle	]2
			700 mg/kg	Fat
			20 mg/kg	Liver
			20 mg/kg	Kidney
		Bovine,ovine, caprine	20 mg/kg	Milk
[Phoxim	Phoxim	Ovine	50 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption]3
			400 mg/kg	Fat
			50 mg/kg	Kidney
		Porcine	20 mg/kg	Muscle
			700 mg/kg	Skin and fat
			20 mg/kg	Liver
			20 mg/kg	Kidney

1. Commision Regulation (EC) N° 1478/2001 of 18 July 2001 (OJ N° L 195, 19.7.2001)

2. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

3. Commision Regulation (EC) N° 807/2001 of 25 April 2001 (OJ N° L 118, 27.4.2001)

2.2.2.

Formamidines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Amitraz	Sum of amitraz and all metabolites containing the 2,4-dimethylaniline (2,4-DMA) moiety, expressed as amitraz	Bovine	200 mg/kg	Fat	]1,2
			200 mg/kg	Liver
			200 mg/kg	Kidney
			10 mg/kg	Milk
		Ovine	400 mg/kg	Fat
			100 mg/kg	Liver
			200 mg/kg	Kidney
			10 mg/kg	Milk
		Porcine	400 mg/kg	Fat and skin
			200 mg/kg	Liver
			200 mg/kg	Kidney
		Bees (honey)	200 mg/kg	Honey

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 2393/1999 of 11 November 1999 (OJ N° L 290, 12.11.1999)

2.2.3.

Pyrethroids

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Cyhalothrin	Cyhalotrin (sum of isomers)	Bovine	500 mg/kg	Fat	Further provisions in Council Directive 94/29/EC are to be observed
			50 mg/kg	Kidney
			50 mg/kg	Milk
Cyfluthrin	Cyfluthrin (sum of isomers)	Bovine	10 mg/kg	Muscle	Further provisions in Council Directive 94/29/EC are to be observed ]1
			50 mg/kg	Fat
			10 mg/kg	Liver
			10 mg/kg	Kidney
			20 mg/kg	Milk
[Deltamethrin	Deltamethrin	Bovine	10 mg/kg	Muscle
			50 mg/kg	Fat
			10 mg/kg	Liver
			10 mg/kg	Kidney
			20 mg/kg	Milk
		Ovine	10 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			50 mg/kg	Fat
			10 mg/kg	Liver
			10 mg/kg	Kidney
		Fin Fish	10 mg/kg	Muscle and skin in natural proportions	]2.3
[Flumethrin	Flumethrin (sum of trans-Z isomers)	Bovine	10 mg/kg	Muscle	]4,5
			150 mg/kg	Fat
			20 mg/kg	Liver
			10 mg/kg	Kidney
			30 mg/kg	Milk
		Ovine Not for use in animals from which milk is produced for human consumption	10 mg/kg	Muscle
			150 mg/kg	Fat
			20 mg/kg	Liver
			10 mg/kg	Kidney

1. Commision Regulation (EC) N° 807/2001 of 25 April 2001 (OJ N° L 118, 27.4.2001) and Corrigendum (OJ N° L133, 16.5.2001)

2. Commision Regulation (EC) N° 1815/2001 of 14 September (OJ N° L 246, 15.9.2001) and Corrigendum (OJ N° L 268, 9.10.2001)

3. Commision Regulation (EC) N° 2162/2001 of 7 Novembre 2001 (OJ N° L 291, 8.11.2001)

4. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

5. Commision Regulation (EC) N° 2391/2000 of 27 October (OJ N° L 276, 28.10.2000)

2.2.4.

Acyl urea derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Diflubenzuron	Diflubenzuron	Salmonidae	1000 mg/kg	Muscle and skin in natural proportions	]1
[Teflubenzuron	Teflubenzuron	Salmonidae	500 mg/kg	Muscle and skin in natural proportions	]2

1. Commision Regulation (EC) N° 2593/1999 of 8 December 1999 (OJ N° L 315, 9.12.1999)

2. Commision Regulation (EC) N° 1931/1999 of 9 September 1999 (OJ N° L 240, 10.9.1999)

2.2.5.

Pyrimidines derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Dicyclanil	Sum of dicyclanil and 2,4,6-triamino- pyrimidine-5-carbonitrile	Ovine	200 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption ]1
			150 mg/kg	Fat
			400 mg/kg	Liver
			400 mg/kg	Kidney

1. Commision Regulation (EC) N° 2391/2000 of 27 October (OJ N° L 276, 28.10.2000)

2.2.6.

Triazine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Cyromazine	Cyromazine	Ovine	300 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption ]1
			300 mg/kg	Fat
			300 mg/kg	Liver
			300 mg/kg	Kidney

1. Commision Regulation (EC) N° 1478/2001 of 18 July 2001 (OJ N° L 195, 19.7.2001)

2.3.	Agents acting against endo- and ectoparasites

2.3.1.

Avermectins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Abamectin	Avermectin B1a	Bovine	10 mg/kg	Fat	]1.2
			20 mg/kg	Liver
		Ovine	20 mg/kg	Muscle
			50 mg/kg	Fat
			25 mg/kg	Liver
			20 mg/kg	Kidney
[Doramectin	Doramectin	Bovine	10 mg/kg	Muscle	Not for use in bovine from which milk is produced for human consumption
			150 mg/kg	Fat
			100 mg/kg	Liver
			30 mg/kg	Kidney
		Porcine, ovine	20 mg/kg	Muscle	Not for use in ovine from which milk is produced for human consumption
			100 mg/kg	Fat
			50 mg/kg	Liver
			30 mg/kg	Kidney
		Deer, including reindeer	20 mg/kg	Muscle	]3,4
			100 mg/kg	Fat
			50 mg/kg	Liver
			30 mg/kg	Kidney
[Emamectin	Emamectin B1a	Salmonidae	100 mg/kg	Muscle and skin in natural proportions	]5
[Eprinomectin	Eprinomectin B1a	Bovine	50 mg/kg	Muscle	]6
			250 mg/kg	Fat
			1500 mg/kg	Liver
			300 mg/kg	Kidney
			20 mg/kg	Milk
[Ivermectin	22,23-Dihydro-avermectin B1a	Bovine	40 mg/kg	Fat	]7
			100 mg/kg	Liver
		Porcine, ovine,equidae	20 mg/kg	Fat
			15 mg/kg	Liver
		Deer, including reindeer	20 mg/kg	Muscle
			100 mg/kg	Fat
			50 mg/kg	Liver
			20 mg/kg	Kidney
[Moxidectin	Moxidectin	Bovine, ovine	50 mg/kg	Muscle	]8,9,10
			500 mg/kg	Fat
			100 mg/kg	Liver
			50 mg/kg	Kidney
			40 mg/kg	Milk
		Ovine	50 mg/kg	Muscle
			500 mg/kg	Fat
			100 mg/kg	Liver
			50 mg/kg	Kidney
		Equidae	50 mg/kg	Muscle
			500 mg/kg	Fat
			100 mg/kg	Liver
			50 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 868/2002 of 24 May 2002 (OJ N° L 137, 25.5.2002)

3. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

4. Commision Regulation (EC) N° 1478/2001 of 18 July 2001 (OJ N° L 195, 19.7.2001)

5. Commision Regulation (EC) N° 1931/1999 of 9 September 1999 (OJ N° L 240, 10.9.1999)

6. Commision Regulation (EC) N° 1943/1999 of 10 September 1999 (OJ N° L 241, 11.9.1999)

7. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

8. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

9. Commision Regulation (EC) N° 1942/1999 of 10 September 1999 (OJ N° L 241, 11.9.1999)

10. Commision Regulation (EC) N° 1553/2001 of 30 July 2001 (OJ N° L 205, 31.7.2001)

2.4.	Agents acting against protozoa

2.4.1.

Triazinetrione derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Toltrazuril	Toltrazuril sulfone	Porcine	100 mg/kg	Muscle
			150 mg/kg	Skin and fat
			500 mg/kg	Liver
			250 mg/kg	Kidney
		Chicken	100 mg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			200 mg/kg	Skin and fat
			600 mg/kg	Liver
			400 mg/kg	Kidney
		Turkey	100 mg/kg	Muscle	]1,2
			200 mg/kg	Skin and fat
			600 mg/kg	Liver
			400 mg/kg	Kidney

1. Commision Regulation (EC) N° 2908/2000 of 29 December (OJ N° L 336, 30.12.2000)

2. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2.4.2.

Quinazolone derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Halofuginone	Halofuginone	Bovine	10 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption ]1
			25 mg/kg	Skin and fat
			30 mg/kg	Liver
			30 mg/kg	Kidney

1. Commision Regulation (EC) N° 2908/2000 of 29 December (OJ N° L 336, 30.12.2000)

2.4.3.

Carbanilides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Imidocarb	Imidocarb	Bovine	300 mg/kg	Muscle	]1
			50 mg/kg	Fat
			2000 mg/kg	Liver
			1500 mg/kg	Kidney
			50 mg/kg	Milk

1. Commision Regulation (EC) N° 2162/2001 of 7 Novembre 2001 (OJ N° L 291, 8.11.2001)

3.	Agents acting on the nervous system

3.1.	Agents acting on the central nervous system

3.1.1.

Butyrophenone tranquillisers

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Azaperone	Sum of azaperone and azaperol	Porcine	100 mg/kg	Muscle	]1
			100 mg/kg	Skin and fat
			100 mg/kg	Liver
			100mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

3.2.	Agents acting on the autonomic nervous system

3.2.1.

Anti-adrenergics

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Carazolol	Carazolol	Bovine	5 mg/kg	Muscle	]1,2
			5 mg/kg	Fat
			15 mg/kg	Liver
			15 mg/kg	Kidney
			1 mg/kg	Milk
		Porcine	5 mg/kg	Muscle
			5 mg/kg	Skin and fat
			25 mg/kg	Liver
			25 mg/kg	Kidney

1. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

2. Commision Regulation (EC) N° 2757/1999 of 22 December 1999 (OJ N° L 331, 23.12.1999)

3.2.2.

b2 sympathomimetic agents

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Clenbuterol hydrochloride	Clenbuterol	Bovine	0.1 mg/kg	Muscle	]1
			0.5 mg/kg	Liver
			0.5 mg/kg	Kidney
			0.05 mg/kg	Milk
		Equidae	0.1 mg/kg	Muscle
			0.5 mg/kg	Liver
			0.5 mg/kg	Kidney

1. Commision Regulation (EC) N° 2391/2000 of 27 October (OJ N° L 276, 28.10.2000)

4.	Anti-inflammatory agents

4.1.	Nonsteroidal anti-inflammatory agents

4.1.1.

Arylpropionic acid derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Caprofen	Caprofen	Bovine	500 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			1000 mg/kg	Fat
			1000 mg/kg	Liver
			1000 mg/kg	Kidney
		Equidae	500 mg/kg	Muscle	]1
			1000 mg/kg	Fat
			1000 mg/kg	Liver
			1000 mg/kg	Kidney
[Vedaprofen	Vedaprofen	Equidae	50 mg/kg	Muscle	]2
			20 mg/kg	Fat
			100 mg/kg	Liver
			1000 mg/kg	Kidney

1. Commision Regulation (EC) N° 1931/1999 of 9 September 1999 (OJ N° L 240, 10.9.1999)

2. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

4.1.2.

Fenamate group derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Flunixin	Flunixin	Bovine	20 mg/kg	Muscle	]1,2
			30 mg/kg	Fat
			300 mg/kg	Liver
			100 mg/kg	Kidney
	5-Hydroxyflunixin	Bovine	40 mg/kg	Milk
	Flunixin	Porcine	50 mg/kg	Muscle
			10 mg/kg	Skin and fat
			200 mg/kg	Liver
			30 mg/kg	Kidney
		Equidae	10 mg/kg	Muscle
			20 mg/kg	Fat
			100 mg/kg	Liver
			200 mg/kg	Kidney
[Tolfenamic acid	Tolfenamic acid	Bovine	50 mg/kg	Muscle	]3
			400 mg/kg	Liver
			100 mg/kg	Kidney
			50 mg/kg	Milk
		Porcine	50 mg/kg	Muscle
			400 mg/kg	Liver
			100 mg/kg	Kidney

1. Commision Regulation (EC) N° 2728/1999 of 20 December 1999 (OJ N° L 328, 22.12.1999)

2. Commision Regulation (EC) N° 2908/2000 of 29 December 2000 (OJ N° L 336, 30.12.2000)

3. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

4.1.3.

Enolic acid derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Meloxicam	Meloxicam	Equidae	20 mg/kg	Muscle	]1.
			65 mg/kg	Liver
			65 mg/kg	Kidney

1. Commision Regulation (EC) N° 1530/2002 of 27 August 2002 (OJ N° L 230, 28.8.2002)

4.1.4.

Oxican derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Meloxicam	Meloxicam	Bovine	20 mg/kg	Muscle	]1.2
			65 mg/kg	Liver
			65 mg/kg	Kidney
			15 mg/kg	Milk
		Porcine	20 mg/kg	Muscle
			65 mg/kg	Liver
			65 mg/kg	Kidney

1. Commision Regulation (EC) N° 2728/1999 of 20 December 1999 (OJ N° L 328, 22.12.1999)

2. Commision Regulation (EC) N° 1274/2001 of 27 June 2001 (OJ N° L 175, 28.6.2001)

5.	Corticoids

5.1.	Glucocorticoids

Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Betamethasone	Betamethasone	Bovine	0,75 mg/kg	Muscle	]1
			2,0 mg/kg	Liver
			0,75 mg/kg	Kidney
			0,3 mg/kg	Milk
		Porcine	0,75 mg/kg	Muscle
			2,0 mg/kg	Liver
			0,75 mg/kg	Kidney
[Dexamethasone	Dexamethasone	Bovine, porcine, equidae	0,75 mg/kg	Muscle	]2
			2,0 mg/kg	Liver
			0,75 mg/kg	Kidney
		Bovine	0,3 mg/kg	Milk
[Methylprednisolone	Methylprednisolone	Bovine	10 mg/kg	Muscle	Not for use in animals from which milk is produced for human consumption]3
			10 mg/kg	Fat
			10 mg/kg	Liver
			10 mg/kg	Kidney
[Prednisolone	Prednisolone	Bovine	4 mg/kg	Muscle	]4
			4 mg/kg	Fat
			10 mg/kg	Liver
			10 mg/kg	Kidney
			6 mg/kg	Milk

1. Commision Regulation (EC) N° 2593/1999 of 8 December 1999 (OJ N° L 315, 9.12.1999)

2. Commision Regulation (EC) N° 508/1999 of 4 March 1999 (OJ N° L 60, 9.3.1999)

3. Commision Regulation (EC) N° 77/2002 of 17 January 2002 (OJ N° L 16, 18.1.2002)

4. Commision Regulation (EC) N° 2535/2000 of 17 November 2000 (OJ N° L 291, 18.11.2000)

6.	Agents acting on reproductive system

6.1.	Progestagens

Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[Chlormadinone	Chlormadinone	Bovine	4 mg/kg	Fat	For zootechnical use only]1
			2 mg/kg	Liver
			2,5 mg/kg	Milk
[Flugestone acetate	Flugestone acetate	Ovine	1 mg/kg	Milk	For intravaginal use for zootechnical purposes only]2

1. Commision Regulation (EC) N° 2584/2001 of 19 December 2001 (OJ N° L 345, 29.12.2001)

2. Commision Regulation (EC) N° 2584/2001 of 19 December 2001 (OJ N° L 345, 29.12.2001)